anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

200,461-200,520 of 319,975

filter-aware
60
The table highlights the delta between cash flow and ex-TAC gross profit, demonstrating the impact of upfront payments on cash flow.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Financials1 hit
61
Financial data presented in millions of dollars.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Financials1 hit
62
The table shows ranges for financial metrics in millions of dollars.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Financials1 hit
63
Standard financial disclosure regarding non-GAAP measures.Taboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Financials1 hit
64
Taboola | Investor Presentation Deck | 64 slidesTaboola | Investor Presentation Deck | 64 slides · Taboola
Pitch deck Investor relations Beat · Financials1 hit
01
Slide 1
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
02
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
03
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
04
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
05
The slide uses stacked bar charts for revenue composition and simple bar charts for session volume.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
06
The slide shows a positive trend in revenue growth and a reduction in Adjusted EBITA loss.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
07
The slide uses a dual-chart layout to compare revenue composition and profitability trends.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
08
The slide shows a decline in Consumer revenue while Payor and DTE revenue show consistent growth throughout 2022.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
09
The slide uses three distinct bar charts to illustrate cost reduction and EBITDA improvement trends.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
10
The slide uses a four-column layout to categorize strategic operational focus areas.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
11
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
12
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
13
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
14
Talkspace | Results Presentation Deck | 15 slidesTalkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
15
Includes detailed footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 15 slides · Talkspace
Conference presentation Investor relations 1 hit
01
Slide 1
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
02
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
03
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
04
The slide uses a three-column layout to summarize corporate actions.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
05
The slide uses a three-column layout to categorize corporate objectives.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Current Reality (Pain)1 hit
06
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
07
The slide uses two bar charts to illustrate growth trends over five quarters.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Quick Win Big Bet1 hit
08
The slide uses a line chart for hospital share and a combo bar/line chart for community share to illustrate market penetration.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
09
The slide outlines a clinical trial methodology using a timeline-based process flow.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
10
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
11
The slide uses a two-part structure: a top section for market sizing/segmentation and a bottom section for a competitive product comparison table.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
12
The chart is a forest plot showing LS Mean differences with 95% confidence intervals.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
13
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
14
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
15
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
16
The slide highlights specific cash flow activities like tax payments and share buybacks.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
17
The chart shows a significant reduction in operating expenses from 2020 to 2023 guidance.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
18
The table displays projected royalties and milestones for 2023-2026. The slide highlights the transition of royalty payments back to Theravance Biopharma starting in 2029.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
19
Uses a curved arrow diagram to represent a progression of value drivers.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Future Vision (Gain)1 hit
20
Slide 20 of the presentation.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
21
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
22
Includes a footnote regarding market research methodology.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
23
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
24
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
25
Theravance Biopharma | Results Presentation Deck | 31 slidesTheravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Beat · The Bridge1 hit
26
Includes abbreviations for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
27
The funnel visualizes the drop-off from total diagnosed COPD patients to those currently on YUPELRI.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
Slide lists specific academic abstracts presented at the 33rd International Symposium on the Autonomic Nervous System.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
29
The slide uses a before-after framework to justify a strategic pivot in clinical trial focus.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations Loop · Before After1 hit
30
Includes a detailed table for Trelegy Ellipta royalties and milestones by year.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
31
Includes cash position, income statement items, and adjusted operating expenses excluding share-based compensation.Theravance Biopharma | Results Presentation Deck | 31 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
01
Slide 1
XP Inc | Results Presentation Deck | 23 slidesXP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations 1 hit
02
XP Inc | Results Presentation Deck | 23 slidesXP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations 1 hit
03
XP Inc | Results Presentation Deck | 23 slidesXP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations 1 hit
04
XP Inc | Results Presentation Deck | 23 slidesXP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations 1 hit
05
XP Inc | Results Presentation Deck | 23 slidesXP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations Beat · Humble OriginsLoop · Before After1 hit
06
The slide contrasts the 2013-2014 period (high cyclicality) with the 2021-2022 period (resilience).XP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations Beat · Humble OriginsLoop · Before After1 hit
07
The slide uses a line chart to represent a timeline of product launches alongside headcount growth.XP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations Beat · Rising Success1 hit
08
The slide highlights growth in both operational capacity (IFAs) and financial scale (Client Assets).XP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations Beat · Rising Success1 hit
09
The slide uses a grid of metrics to show current penetration and a list of callouts to explain the strategic value of increasing these numbers.XP Inc | Results Presentation Deck | 23 slides · XP Inc
Conference presentation Investor relations Beat · Rising Success1 hit